Among the study patients, 38% of those with RMS, 53% of those with synovial sarcoma, 33% of those with Ewing sarcoma, 100% of those with epithelioid sarcoma, and 0% of those with mesenchymal chondrosarcoma showed positive PD-L1 expressions. The gene discussed is CD274; the disease is synovial sarcoma.